Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia

Epigenetics

Volumn 7, Issue 11, 2012, Pages 1268-1278

  Lendvai, Ágnes ^a   Johannes, Frank ^b   Grimm, Christina ^c,d   Eijsink, Jasper J H ^a   Wardenaar, René ^b   Volders, Haukeline H ^a   Klip, Harry G ^a   Hollema, Harry ^a   Jansen, Ritsert C ^b   Schuuring, Ed ^a   Wisman, G Bea A ^a   van der Zee, Ate G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cervical precancerous lesion; Cervical scraping; DNA methylation; MeDIP chip

Indexed keywords

EID: 84868370483     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.22301     Document Type: Article

References (64)

1. Wentzensen N, Klug SJ. Early detection of cervical carcinomas: finding an overall approach. Dtsch Arztebl Int 2008; 105:617-622. PMID:19471627.
2. Robertson JH, Woodend B. Negative cytology preceding cervical cancer: causes and prevention. J Clin Pathol 1993; 46:700-702. PMID:8408692; http://dx.doi.org/10.1136/jcp.46.8.700.
3. Koss LG. Cervical (Pap) smear. New directions. Cancer 1993; 71(Suppl):1406-1412. PMID:8381706; http://dx.doi.org/10.1002/cncr.2820710405.
4. Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE. How to evaluate emerging technologies in cervical cancer screening? Int J Cancer 2009; 125:2489-2496. PMID:19626591; http://dx.doi.org/10.1002/ijc.24774.
5. Bulkmans NW, Rozendaal L, Snijders PJ, Voorhorst FJ, Boeke AJ, Zandwijken GR, et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 2004; 110:94-101. PMID:15054873; http://dx.doi.org/10.1002/ijc.20076.
6. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al.; Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357:1579-1588. PMID:17942871; http://dx.doi.org/10.1056/NEJMoa071430.
7. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al.; New Technologies for Cervical Cancer Screening Working Group. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008; 100:492-501. PMID:18364502; http://dx.doi.org/10.1093/jnci/djn065.
8. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, et al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst 2009; 101:88-99. PMID:19141778; http://dx.doi.org/10.1093/jnci/djn444.
9. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 2009; 112:293-299. PMID:19054549; http://dx.doi.org/10.1016/j.ygyno.2008.10.012.
10. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007; 7:11-22. PMID:17186016; http://dx.doi.org/10.1038/nrc2050.
11. Yang N, Eijsink JJ, Lendvai A, Volders HH, Klip H, Buikema HJ, et al. Methylation markers for CCNA1 and C13ORF18 are strongly associated with highgrade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev 2009; 18:3000-3007. PMID:19843677; http://dx.doi.org/10.1158/1055-9965.EPI-09-0405.
12. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 2005; 97:273-282. PMID:15713962; http://dx.doi.org/10.1093/jnci/dji041.
13. Lim EH, Ng SL, Li JL, Chang AR, Ng J, Ilancheran A, et al. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol 2010; 119:225-231. PMID:20708786; http://dx.doi.org/10.1016/j.ygyno.2010.07.028.
14. Missaoui N, Hmissa S, Trabelsi A, Traoré C, Mokni M, Dante R, et al. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Pathol Res Pract 2011; 207:37-42. PMID:21129853; http://dx.doi.org/10.1016/j.prp.2010.11.001.
15. Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 96:294-305. PMID:14970278; http://dx.doi.org/10.1093/jnci/djh031.
16. Overmeer RM, Louwers JA, Meijer CJ, van Kemenade FJ, Hesselink AT, Daalmeijer NF, et al. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. Int J Cancer 2011; 129:2218-2225. PMID:21190187; http://dx.doi.org/10.1002/ijc.25890.
17. Hesselink AT, Heideman DA, Steenbergen RD, Coupé VM, Overmeer RM, Rijkaart D, et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res 2011; 17:2459-2465. PMID:21389098; http://dx.doi.org/10.1158/1078-0432.CCR-10-2548.
18. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 2010; 11:191-203. PMID:20125086; http://dx.doi.org/10.1038/nrg2732.
19. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, et al. Chromosome-wide and promoterspecific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005; 37:853-862. PMID:16007088; http://dx.doi.org/10.1038/ng1598.
20. Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007; 39:457-466. PMID:17334365; http://dx.doi.org/10.1038/ng1990.
21. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012; 22:271-282. PMID:21659424; http://dx.doi.org/10.1101/gr.117523.110.
22. Eijsink JJ, Lendvai A, Deregowski V, Klip HG, Verpooten G, Dehaspe L, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer 2012; 130:1861-1869. PMID:21796628; http://dx.doi.org/10.1002/ijc.26326.
23. Yang N, Nijhuis ER, Volders HH, Eijsink JJ, Lendvai A, Zhang B, et al. Gene promoter methylation patterns throughout the process of cervical carcinogenesis. Cell Oncol 2010; 32:131-143. PMID:20208141.
24. Novak P, Jensen TJ, Garbe JC, Stampfer MR, Futscher BW. Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. Cancer Res 2009; 69:5251-5258. PMID:19509227; http://dx.doi.org/10.1158/0008-5472.CAN-08-4977.
25. Henken FE, Wilting SM, Overmeer RM, van Rietschoten JG, Nygren AO, Errami A, et al. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 2007; 97:1457-1464. PMID:17971771; http://dx.doi.org/10.1038/sj.bjc.6604055.
26. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 2008; 123:161-167. PMID:18398837; http://dx.doi.org/10.1002/ijc.23519.
27. Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, et al. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 2008; 68:2661-2670. PMID:18413733; http://dx.doi.org/10.1158/0008-5472.CAN-07-5913.
28. Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, et al. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res 2008; 68:2489-2497. PMID:18381458; http://dx.doi.org/10.1158/0008-5472.CAN-07-3194.
29. Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, et al. DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer 2009; 125:2995-3002. PMID:19609949; http://dx.doi.org/10.1002/ijc.24745.
30. Rauch TA, Wang Z, Wu X, Kernstine KH, Riggs AD, Pfeifer GP. DNA methylation biomarkers for lung cancer. Tumour Biol 2012; 33:287-296. PMID:22143938; http://dx.doi.org/10.1007/s13277-011-0282-2.
31. Dunwell T, Hesson L, Rauch TA, Wang L, Clark RE, Dallol A, et al. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol Cancer 2010; 9:44. PMID:20184741; http://dx.doi.org/10.1186/1476-4598-9-44.
32. Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP. Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res 2009; 11:R14. PMID:19250546; http://dx.doi.org/10.1186/bcr2233.
33. Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A 2008; 105:252-257. PMID:18162535; http://dx.doi.org/10.1073/pnas.0710735105.
34. Hill VK, Hesson LB, Dansranjavin T, Dallol A, Bieche I, Vacher S, et al. Identification of 5 novel genes methylated in breast and other epithelial cancers. Mol Cancer 2010; 9:51. PMID:20205715; http://dx.doi.org/10.1186/1476-4598-9-51.
35. Kuang SQ, Tong WG, Yang H, Lin W, Lee MK, Fang ZH, et al. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia 2008; 22:1529-1538. PMID:18528427; http://dx.doi.org/10.1038/leu.2008.130.
36. Tong WG, Wierda WG, Lin E, Kuang SQ, Bekele BN, Estrov Z, et al. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 2010; 5:499-508. PMID:20484983; http://dx.doi.org/10.4161/epi.5.6.12179.
37. Fassbender A, Lewin J, König T, Rujan T, Pelet C, Lesche R, et al. Quantitative DNA methylation profiling on a high-density oligonucleotide microarray. Methods Mol Biol 2010; 576:155-170. PMID:19882262; http://dx.doi.org/10.1007/978-1-59745-545-9_9.
38. Cheong HS, Lee HC, Park BL, Kim H, Jang MJ, Han YM, et al. Epigenetic modification of retinoic acid-treated human embryonic stem cells. BMB Rep 2010; 43:830-835. PMID:21189161; http://dx.doi.org/10.5483/BMBRep.2010.43.12.830.
39. Mishra DK, Chen Z, Wu Y, Sarkissyan M, Koeffler HP, Vadgama JV. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol Cancer Ther 2010; 9:33-45. PMID:20053773; http://dx.doi.org/10.1158/1535-7163.MCT-09-0486.
40. Old RW, Crea F, Puszyk W, Hultén MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online 2007; 15:227-235. PMID:17697502; http://dx.doi.org/10.1016/S1472-6483(10)60713-4.
41. Maekawa R, Yagi S, Ohgane J, Yamagata Y, Asada H, Tamura I, et al. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma. J Reprod Dev 2011; 57:604-612. PMID:21685710; http://dx.doi.org/10.1262/jrd.11-035A.
42. Lopes AM, Ross N, Close J, Dagnall A, Amorim A, Crow TJ. Inactivation status of PCDH11X: sexual dimorphisms in gene expression levels in brain. Hum Genet 2006; 119:267-275. PMID:16425037; http://dx.doi.org/10.1007/s00439-006-0134-0.
43. Bennett LB, Schnabel JL, Kelchen JM, Taylor KH, Guo J, Arthur GL, et al. DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer 2009; 48:828-841. PMID:19530241; http://dx.doi.org/10.1002/gcc.20687.
44. Chelbi ST, Doridot L, Mondon F, Dussour C, Rebourcet R, Busato F, et al. Combination of promoter hypomethylation and PDX1 overexpression leads to TBX15 decrease in vascular IUGR placentas. Epigenetics 2011; 6:247-255. PMID:20962579; http://dx.doi.org/10.4161/epi.6.2.13791.
45. Kalari S, Pfeifer GP. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet 2010; 70:277-308. PMID:20920752; http://dx.doi.org/10.1016/B978-0-12-380866-0.60010-1.
46. Jin B, Yao B, Li JL, Fields CR, Delmas AL, Liu C, et al. DNMT1 and DNMT3B modulate distinct polycombmediated histone modifications in colon cancer. Cancer Res 2009; 69:7412-7421. PMID:19723660; http://dx.doi.org/10.1158/0008-5472.CAN-09-0116.
47. Halaban R, Krauthammer M, Pelizzola M, Cheng E, Kovacs D, Sznol M, et al. Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PLoS One 2009; 4:e4563. PMID:19234609; http://dx.doi.org/10.1371/journal.pone.0004563.
48. Shih IeM, Chen L, Wang CC, Gu J, Davidson B, Cope L, et al. Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis. Am J Obstet Gynecol 2010; 203:584/622, e1-e22. PMID:20965493; http://dx.doi.org/10.1016/j.ajog.2010.08.003.
49. Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007; 27:562-572. PMID:17707228; http://dx.doi.org/10.1016/j.molcel.2007.06.039.
50. Papageorgio C, Harrison R, Rahmatpanah FB, Taylor K, Davis W, Caldwell CW. Algorithmic discovery of methylation "hot spots" in DNA from lymphoma patients. Cancer Inform 2008; 6:449-453. PMID:19259422.
51. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178-186. PMID:19151715; http://dx.doi.org/10.1038/ng.298.
52. Brinkman AB, Simmer F, Ma K, Kaan A, Zhu J, Stunnenberg HG. Whole-genome DNA methylation profiling using MethylCap-seq. Methods 2010; 52:232-236. PMID:20542119; http://dx.doi.org/10.1016/j.ymeth.2010.06.012.
53. Wild L, Flanagan JM. Genome-wide hypomethylation in cancer may be a passive consequence of transformation. Biochim Biophys Acta 2010; 1806:50-57. PMID:20398739.
54. Missaoui N, Hmissa S, Dante R, Frappart L. Global DNA methylation in precancerous and cancerous lesions of the uterine cervix. Asian Pac J Cancer Prev 2010; 11:1741-1744. PMID:21338225.
55. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107-116. PMID:16491070; http://dx.doi.org/10.1038/nrc1799.
56. Söderberg L, Dahlqvist C, Kakuyama H, Thyberg J, Ito A, Winblad B, et al. Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates. FEBS J 2005; 272:2231-2236. PMID:15853808; http://dx.doi.org/10.1111/j.1742-4658.2005.04647.x.
57. Tong Y, Xu Y, Scearce-Levie K, Ptácek LJ, Fu YH. COL25A1 triggers and promotes Alzheimer's diseaselike pathology in vivo. Neurogenetics 2010; 11:41-52. PMID:19548013; http://dx.doi.org/10.1007/s10048-009-0201-5.
58. Chavez L, Jozefczuk J, Grimm C, Dietrich J, Timmermann B, Lehrach H, et al. Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res 2010; 20:1441-1450. PMID:20802089; http://dx.doi.org/10.1101/gr.110114.110.
59. Grimm C, Adjaye J. Analysis of the methylome of human embryonic stem cells employing methylated DNA immunoprecipitation coupled to next-generation sequencing. Methods Mol Biol 2012; 873:281-295. PMID:22528363; http://dx.doi.org/10.1007/978-1-61779-794-1_19.
60. Butcher LM, Beck S. Auto MeDIP-seq: a high-throughput, whole genome, DNA methylation assay. Methods 2010; 52:223-231. PMID:20385236; http://dx.doi.org/10.1016/j.ymeth.2010.04.003.
61. Team RDC. A language and environment for statistical computing. 2011, Vienna, Austria.
62. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res 2004; 32(Database issue):D493-D496. PMID:14681465; http://dx.doi.org/10.1093/nar/gkh103.
63. Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37:1-13. PMID:19033363; http://dx.doi.org/10.1093/nar/gkn923.
64. Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57. PMID:19131956; http://dx.doi.org/10.1038/nprot.2008.211.